Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05197322
Title NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer (NEOPRISM-CRC)
Acronym NEOPRISM-CRC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University College, London
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR

Additional content available in CKB BOOST